Dov A. Goldstein MD
Chief Financial Officer at BioAge Labs · 9 reported transactions in 2 companies · latest trade Jan 13, 2026
Their trades
Sold | Jan 13, 2026 | Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days. | ||
Sold | Jan 13, 2026 | Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days. | ||
Sold | Jan 13, 2026 | Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days. | ||
Sold | Jan 13, 2026 | Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days. |
SoldBioAge Labs
$40.5K
Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days.
SoldBioAge Labs
$239.5K
Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days.
SoldBioAge Labs
$86.4K
Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days.
SoldBioAge Labs
$165.4K
Jan 13, 2026 close $20.69 → Oct 28, 2026 close $5.94. S&P 500 +11.3% over the same days.